Market openADR
PureTech Health/$PRTC
14:30
22:10
05:45
13:25
21:00
1D1W1MYTD1Y5YMAX
About PureTech Health
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
Ticker
$PRTC
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
90
Website
PureTech Health Metrics
BasicAdvanced
$487M
Market cap
-
P/E ratio
-$0.30
EPS
1.00
Beta
-
Dividend rate
Price and volume
Market cap
$487M
Beta
1
52-week high
$34.00
52-week low
$17.08
Average daily volume
5.4K
Financial strength
Current ratio
3.679
Quick ratio
3.633
Long term debt to equity
43.722
Total debt to equity
47.267
Interest coverage (TTM)
-6.80%
Management effectiveness
Return on assets (TTM)
-13.39%
Return on equity (TTM)
-22.07%
Valuation
Price to revenue (TTM)
12,093.023
Price to book
1.19
Price to tangible book (TTM)
1.19
Price to free cash flow (TTM)
-46.768
Growth
Revenue change (TTM)
-96.01%
Earnings per share change (TTM)
78.63%
3-year revenue growth (CAGR)
-64.83%
3-year earnings per share growth (CAGR)
-23.47%
What the Analysts think about PureTech Health
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for PureTech Health stock.
PureTech Health Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
PureTech Health Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
PureTech Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for PureTech Health stock?
PureTech Health (PRTC) has a market cap of $487M as of November 08, 2024.
What is the P/E ratio for PureTech Health stock?
The price to earnings (P/E) ratio for PureTech Health (PRTC) stock is 0 as of November 08, 2024.
Does PureTech Health stock pay dividends?
No, PureTech Health (PRTC) stock does not pay dividends to its shareholders as of November 08, 2024.
When is the next PureTech Health dividend payment date?
PureTech Health (PRTC) stock does not pay dividends to its shareholders.
What is the beta indicator for PureTech Health?
PureTech Health (PRTC) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.